{"id":"https://openalex.org/W1990535802","doi":"https://doi.org/10.1007/s00213-007-0974-x","title":"The mGlu2 but not the mGlu3 receptor mediates the actions of the mGluR2/3 agonist, LY379268, in mouse models predictive of antipsychotic activity","display_name":"The mGlu2 but not the mGlu3 receptor mediates the actions of the mGluR2/3 agonist, LY379268, in mouse models predictive of antipsychotic activity","publication_year":2007,"publication_date":"2007-12-04","ids":{"openalex":"https://openalex.org/W1990535802","doi":"https://doi.org/10.1007/s00213-007-0974-x","mag":"1990535802","pmid":"https://pubmed.ncbi.nlm.nih.gov/18057917"},"language":"en","primary_location":{"id":"doi:10.1007/s00213-007-0974-x","doi":"https://doi.org/10.1007/s00213-007-0974-x","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s00213-007-0974-x","pdf_url":null,"source":{"id":"https://openalex.org/S80334769","display_name":"Psychopharmacology","issn_l":"0033-3158","issn":["0033-3158","1432-2072"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111746838","display_name":"Marie L. Woolley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"M. L. Woolley","raw_affiliation_strings":["GlaxoSmithKline plc, Harlow, Essex, CM19 5AW, UK. marie.2.woolley-roberts@gsk.com","GlaxoSmithKline plc.;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline plc, Harlow, Essex, CM19 5AW, UK. marie.2.woolley-roberts@gsk.com","institution_ids":["https://openalex.org/I188950975"]},{"raw_affiliation_string":"GlaxoSmithKline plc.;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014392907","display_name":"Darrel J. Pemberton","orcid":"https://orcid.org/0000-0002-4778-280X","observed_orcids":["https://orcid.org/0000-0002-4778-280X"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"D. J. Pemberton","raw_affiliation_strings":["Psychiatry CEDD, GlaxoSmithKline plc, New Frontiers Science Park, Third Avenue, Harlow, Essex, CM19 5AW, UK","GlaxoSmithKline plc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatry CEDD, GlaxoSmithKline plc, New Frontiers Science Park, Third Avenue, Harlow, Essex, CM19 5AW, UK","institution_ids":["https://openalex.org/I188950975"]},{"raw_affiliation_string":"GlaxoSmithKline plc","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075216164","display_name":"Simon T. Bate","orcid":"https://orcid.org/0000-0001-6736-2864","observed_orcids":["https://orcid.org/0000-0001-6736-2864"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"S. Bate","raw_affiliation_strings":["Statistical Sciences, GlaxoSmithKline plc, Third Avenue, Harlow, Essex, CM19 5AW, UK","GlaxoSmithKline plc.;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Statistical Sciences, GlaxoSmithKline plc, Third Avenue, Harlow, Essex, CM19 5AW, UK","institution_ids":["https://openalex.org/I188950975"]},{"raw_affiliation_string":"GlaxoSmithKline plc.;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046908097","display_name":"Corrado Corti","orcid":"https://orcid.org/0000-0002-7876-9114","observed_orcids":["https://orcid.org/0000-0002-7876-9114"]},"institutions":[{"id":"https://openalex.org/I4210128413","display_name":"GlaxoSmithKline (Italy)","ror":"https://ror.org/03fe56089","country_code":"IT","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210128413"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"C. Corti","raw_affiliation_strings":["Psychiatry Centre of Excellence for Drug Discovery, GlaxoSmithKline Medicines Research Centre, Via Fleming, 37135, Verona, Italy","GlaxoSmithKline Medicines Research Centre;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatry Centre of Excellence for Drug Discovery, GlaxoSmithKline Medicines Research Centre, Via Fleming, 37135, Verona, Italy","institution_ids":["https://openalex.org/I4210128413"]},{"raw_affiliation_string":"GlaxoSmithKline Medicines Research Centre;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053289107","display_name":"Declan N.C. Jones","orcid":"https://orcid.org/0000-0001-6988-3604","observed_orcids":["https://orcid.org/0000-0001-6988-3604"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"D. N. C. Jones","raw_affiliation_strings":["Psychiatry CEDD, GlaxoSmithKline plc, New Frontiers Science Park, Third Avenue, Harlow, Essex, CM19 5AW, UK","GlaxoSmithKline plc.;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatry CEDD, GlaxoSmithKline plc, New Frontiers Science Park, Third Avenue, Harlow, Essex, CM19 5AW, UK","institution_ids":["https://openalex.org/I188950975"]},{"raw_affiliation_string":"GlaxoSmithKline plc.;","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5111746838"],"corresponding_institution_ids":["https://openalex.org/I188950975"],"apc_list":{"value":4390,"currency":"USD","value_usd":4390},"apc_paid":null,"fwci":9.6461,"has_fulltext":false,"cited_by_count":189,"citation_normalized_percentile":{"value":0.98594234,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":90,"max":100},"biblio":{"volume":"196","issue":"3","first_page":"431","last_page":"440"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.7710000276565552,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.7710000276565552,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.1746000051498413,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.026000000536441803,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mglur3","display_name":"mGluR3","score":1.0},{"id":"https://openalex.org/keywords/ly379268","display_name":"LY379268","score":0.9200000166893005},{"id":"https://openalex.org/keywords/group-ii-metabotropic-glutamate-receptors","display_name":"group II metabotropic glutamate receptors","score":0.9610000252723694},{"id":"https://openalex.org/keywords/antipsychotic-activity","display_name":"antipsychotic activity","score":0.8799999952316284},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.703000009059906},{"id":"https://openalex.org/keywords/amphetamine-induced-hyperactivity","display_name":"amphetamine-induced hyperactivity","score":0.9919999837875366},{"id":"https://openalex.org/keywords/locomotor-activity","display_name":"locomotor activity","score":0.6570000052452087},{"id":"https://openalex.org/keywords/transgenic-mice","display_name":"transgenic mice","score":0.5580000281333923},{"id":"https://openalex.org/keywords/receptor-selectivity","display_name":"receptor selectivity","score":0.35100001096725464}],"concepts":[{"id":"https://openalex.org/C119128870","wikidata":"https://www.wikidata.org/wiki/Q4859538","display_name":"Metabotropic glutamate receptor 2","level":5,"score":0.8740873336791992},{"id":"https://openalex.org/C2777193897","wikidata":"https://www.wikidata.org/wiki/Q179452","display_name":"Amphetamine","level":3,"score":0.8015990257263184},{"id":"https://openalex.org/C49051014","wikidata":"https://www.wikidata.org/wiki/Q2033959","display_name":"Metabotropic glutamate receptor","level":4,"score":0.6418348550796509},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.554585874080658},{"id":"https://openalex.org/C26702167","wikidata":"https://www.wikidata.org/wiki/Q901988","display_name":"Metabotropic receptor","level":4,"score":0.5365346670150757},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5145654082298279},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.37165918946266174},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3536413908004761},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.346005916595459},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.2816706895828247},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2530929744243622},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.13131925463676453},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.12543347477912903}],"mesh":[{"descriptor_ui":"D000596","descriptor_name":"Amino Acids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000596","descriptor_name":"Amino Acids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000661","descriptor_name":"Amphetamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001522","descriptor_name":"Behavior, Animal","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006948","descriptor_name":"Hyperkinesis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009043","descriptor_name":"Motor Activity","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018094","descriptor_name":"Receptors, Metabotropic Glutamate","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D018094","descriptor_name":"Receptors, Metabotropic Glutamate","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D018345","descriptor_name":"Mice, Knockout","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019086","descriptor_name":"Bridged Bicyclo Compounds, Heterocyclic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019086","descriptor_name":"Bridged Bicyclo Compounds, Heterocyclic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1007/s00213-007-0974-x","doi":"https://doi.org/10.1007/s00213-007-0974-x","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s00213-007-0974-x","pdf_url":null,"source":{"id":"https://openalex.org/S80334769","display_name":"Psychopharmacology","issn_l":"0033-3158","issn":["0033-3158","1432-2072"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:18057917","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18057917","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":35,"referenced_works":["https://openalex.org/W1966348190","https://openalex.org/W1970741065","https://openalex.org/W1972722155","https://openalex.org/W1974900636","https://openalex.org/W1981763442","https://openalex.org/W1983664266","https://openalex.org/W1991964519","https://openalex.org/W2011577168","https://openalex.org/W2019110706","https://openalex.org/W2022570764","https://openalex.org/W2028436439","https://openalex.org/W2042370460","https://openalex.org/W2060974385","https://openalex.org/W2061506085","https://openalex.org/W2067795636","https://openalex.org/W2069102021","https://openalex.org/W2071090720","https://openalex.org/W2072471087","https://openalex.org/W2076116201","https://openalex.org/W2078977508","https://openalex.org/W2105962778","https://openalex.org/W2106042714","https://openalex.org/W2108268535","https://openalex.org/W2115012618","https://openalex.org/W2116386279","https://openalex.org/W2116896173","https://openalex.org/W2121473111","https://openalex.org/W2130743173","https://openalex.org/W2133176999","https://openalex.org/W2146112646","https://openalex.org/W2147197593","https://openalex.org/W2165050824","https://openalex.org/W2318283658","https://openalex.org/W2943844886","https://openalex.org/W4315698256"],"related_works":["https://openalex.org/W2116896173","https://openalex.org/W2113113845","https://openalex.org/W2268085396","https://openalex.org/W1996855868","https://openalex.org/W2060974385","https://openalex.org/W2073958693","https://openalex.org/W1979981960","https://openalex.org/W25219310","https://openalex.org/W2133176999","https://openalex.org/W2030205241"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2022,"cited_by_count":11},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":13},{"year":2015,"cited_by_count":14},{"year":2014,"cited_by_count":14},{"year":2013,"cited_by_count":12},{"year":2012,"cited_by_count":23}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}